Withdrawal of mycophenolate mofetil in stable renal transplant patients

被引：1
|
作者：
Kaplan, B
Meier-Kriesche, HU
Friedman, G
Mulgaonkar, S
Vaghela, M
Duva, D
Nittoly, M
Jacobs, M
机构：
[1] St Barnabas Med Ctr, Dept Transplantat, Livingston, NJ USA
[2] Univ Texas, Sch Med, Div Renal Dis & Hypertens, Houston, TX USA
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00468
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
440
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [21] Variability of mycophenolate mofetil trough levels in stable kidney transplant patients
    Fernandez, A.
    Martins, J.
    Villlafruela, J. J.
    Marcen, R.
    Pascual, J.
    Cano, T.
    Puig, C.
    Gil-Casares, B.
    Muriel, A.
    Burgos, F. J.
    Ortuno, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2185 - 2186
  • [22] Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels
    van Besouw, NM
    van der Mast, BJ
    Gregoor, PJHS
    Hesse, CJ
    IJzermans, JNM
    van Gelder, T
    Weimar, W
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2710 - 2713
  • [23] Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
    Lobritto, Steven J.
    Rosenthal, Philip
    Bouw, Rene
    Leung, Mimi
    Snell, Paul
    Mamelok, Richard D.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (11) : 1570 - 1575
  • [24] Mycophenolate mofetil-induced colonic ulcerations in renal transplant patients
    Ali, T
    Sachdev, A
    Squires, RA
    Guild, RT
    Mesiya, SA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S199 - S200
  • [25] Villous atrophy induced by mycophenolate mofetil in renal-transplant patients
    Kamar, N
    Faure, P
    Dupuis, E
    Cointault, O
    Joseph-Hein, K
    Durand, D
    Moreau, J
    Rostaing, L
    [J]. TRANSPLANT INTERNATIONAL, 2004, 17 (08) : 463 - 467
  • [26] Clinical Significance of Mycophenolate Mofetil Withdrawal in Kidney Transplant Recipients
    Park, Woo Yeong
    Paek, Jin Hyuk
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (08) : 2633 - 2636
  • [27] Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario
    Srivastava, A
    Singh, V
    Kumar, A
    Sharma, RK
    Gupta, A
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2060 - 2064
  • [28] Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients
    Kato, Yojiro
    Tojimbara, Tamotsu
    Iwadoh, Kazuhiro
    Koyama, Ichiro
    Nanmoku, Koji
    Kai, Kotaro
    Sannomiya, Akihito
    Nakajima, Ichiro
    Fuchinoue, Shohei
    Teraoka, Satoshi
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (13-14) : 1984 - 1992
  • [29] Mycophenolate mofetil levels in stable kidney transplant recipients
    Fernandez, A.
    Marcen, R.
    Pascual, J.
    Martins, J.
    Villafruela, J. J.
    Cano, T.
    Sabater, J.
    Puig, C.
    Gil-Casares, B.
    Muriel, A.
    Burgos, J.
    Ortuna, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2182 - 2184
  • [30] Benefits of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in pediatric renal transplant patients with stable graft function
    Meneses, Rejane de Paula
    Kotsifas, Cecilia Halusch
    [J]. PEDIATRIC TRANSPLANTATION, 2009, 13 (02) : 188 - 193
12345